Author | Christopher-Paul Milne, DVM, MPH, JD

Articles

Challenges to the FDA Review Process: Cost Considerations and Long-Term Benefit Benchmarks

February 23, 2012

In this interview, Christopher-Paul Milne and Kenneth Kaitin, Tufts Center for the Study of Drug Development. discuss the current challenges of the US Food and Drug Administration review process as it relates to oncology therapeutics and upcoming changes to the Prescription Drug User Fee Act.